✦ LIBER ✦

Protein LA, a novel hybrid protein with unique single-chain Fv antibody- and Fab-binding properties

✍ Scribed by Henrik G. Svensson; Hennie R. Hoogenboom; Ulf Sjöbring

Book ID: 114429549
Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 273 KB
Volume: 258
Category: Article
ISSN: 1432-1327
DOI: 10.1046/j.1432-1327.1998.2580890.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting an extracellular epitope of th

Targeting an extracellular epitope of the human multidrug resistance protein 1 (MRP1) in malignant cells with a novel recombinant single chain Fv antibody

✍ Liat Binyamin; Yehuda G. Assaraf; Maya Haus-Cohen; Michal Stark; Yoram Reiter 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 305 KB 👁 1 views

## Abstract Inherent and acquired multidrug resistance (MDR) is characterized by a simultaneous resistance to diverse anticancer drugs and is a major impediment towards curative chemotherapy of cancer. Hence one important goal is to develop strategies aimed at specific targeting of major anticancer

A novel anti-prion protein monoclonal an

A novel anti-prion protein monoclonal antibody and its single-chain fragment variable derivative with ability to inhibit abnormal prion protein accumulation in cultured cells

✍ Yoshihisa Shimizu; Yuko Kaku-Ushiki; Yoshifumi Iwamaru; Tamaki Muramoto; Tetsuyu 📂 Article 📅 2010 🏛 Center for Academic Publications, Japan 🌐 English ⚖ 384 KB

Probing ATP-dependent conformational cha

Probing ATP-dependent conformational changes in the multidrug resistance protein 1 (MRP1/ABCC1) in live tumor cells with a novel recombinant single-chain Fv antibody targeted to the extracellular N-terminus

✍ Liat Binyamin; Yehuda G. Assaraf; Yoram Reiter 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 1 views

The multidrug resistance protein 1 (MRP1/ABCC1) is an ATPdriven transporter that mediates the cellular extrusion of various chemotherapeutic agents. We have previously isolated a novel recombinant single-chain Fv antibody (A5scFv), which specifically targets the extracellular N-terminus of the human